Phytochem Remedies IPO on 18 Dec.

Phytochem Remedies IPO

Phytochem Remedies (India) Ltd. is launching a Fixed Price SME IPO of Rs. 38.22 crore, comprising an entirely fresh issue of 39,00,000 equity shares. The issue aims to support capacity expansion, reduce debt, and strengthen the company’s balance sheet.

The IPO opens for subscription on Thursday, December 18, 2025, and closes on Monday, December 22, 2025. The shares are proposed to be listed on BSE SME, with a tentative listing date of Friday, December 26, 2025.

🕗 Last Update: 15 December 2025, 6.00 AM

👉 GMP | Reviews | Subscription | Allotment

👉 Chanakya Grey Market Intelligence – 8 PM Edition | News Crux | 

👉 Power Calls | Breakout Stocks | Coffee Can Portfolio


Phytochem Remedies IPO – Key Details

Particulars Details
IPO Dates Dec 18, 2025 – Dec 22, 2025
Listing BSE SME
Face Value Rs. 10 per share
Issue Price Rs. 98 per share
Lot Size 1,200 shares
Issue Size 39,00,000 shares (Rs. 38.22 Cr)
Issue Type Fixed Price IPO
Sale Type Entirely Fresh Issue
Market Maker Portion 1,96,800 shares (Rs. 1.93 Cr)
Net Offer to Public 37,03,200 shares (Rs. 36.29 Cr)
Pre-Issue Shares 78,75,000
Post-Issue Shares 1,17,75,000
Market Cap (Pre-IPO) To be declared

Phytochem Remedies IPO Timeline (Tentative)

Event Date
IPO Open Thu, Dec 18, 2025
IPO Close Mon, Dec 22, 2025
Allotment Tue, Dec 23, 2025
Refunds Wed, Dec 24, 2025
Shares in Demat Wed, Dec 24, 2025
Listing Date Fri, Dec 26, 2025
UPI Cut-off 5 PM, Dec 22, 2025

Phytochem Remedies IPO Reservation Structure

Investor Category Shares Offered % of Issue
Market Maker 1,96,800 5.05%
NII (HNI) 18,51,600 47.48%
Retail 18,51,600 47.48%
Total 39,00,000 100%

Phytochem Remedies IPO Lot Size

Category Lots Shares Amount (Rs.)
Retail (Min–Max) 2 2,400 2,35,200
HNI (Min) 3 3,600 3,52,800

Company Financials (Rs. in Crore)

Period Ended 31-Dec-24 31-Mar-24 31-Mar-23 31-Mar-22
Assets 43.73 41.85 37.07 21.47
Total Income 26.34 32.90 20.83 13.92
PAT 3.07 2.31 0.82 0.53
EBITDA 6.42 5.88 2.91 1.01
Net Worth 11.73 8.74 6.42 5.23
Reserves & Surplus 8.58 5.51 3.20 2.38

Key Performance Indicators

KPI Value
ROE 26.46%
ROCE 18.09%
Debt / Equity 2.41
RoNW 26.46%
PAT Margin 7.04%
EBITDA Margin 17.91%

Promoters & Shareholding

  • Promoters: Aditi Bohra, Bohra Agrifilms Private Limited, Niranjan Surana, Shilpa Surana

  • Promoter Holding (Pre-IPO): 100.00%

  • Promoter Holding (Post-IPO): 66.88%


About Phytochem Remedies (India) Ltd.

Incorporated in 2002, Phytochem Remedies (India) Ltd. is engaged in the manufacturing of corrugated boxes and corrugated board solutions, catering to industries such as FMCG, food & beverages, pesticides, pharmaceuticals, and automotive. The company operates from Jammu, India.

The company has two manufacturing units at Bari Brahmana, Jammu.

  • Unit 1: Total area 43,360 sq. ft. (utilized ~12,000 sq. ft.)

  • Unit 2: Total area 1,73,440 sq. ft. (utilized ~55,000 sq. ft.)

As on December 31, 2024, the company employed 46 people.

Product Portfolio

  • Corrugated Boxes (3-ply, 5-ply, 7-ply)

  • Printed Corrugated Boxes

  • Corrugated Rolls

  • Corrugated Pads & Sheets


Competitive Strengths

  • Long-standing relationships with a stable customer base

  • Consistent financial growth and improving profitability

  • Well-established manufacturing facilities with expansion readiness

  • Diversified product portfolio serving multiple industries


Objects of the Issue

S. No. Purpose Amount (Rs. in Cr)
1 Capital expenditure for equipment & machinery 11.34
2 Capital expenditure towards civil construction 6.21
3 Repayment / pre-payment of borrowings 9.15
4 General corporate purposes

Company Contact

Phytochem Remedies (India) Ltd.
Bari Brahmana, Jammu, India


Lead Manager

Mefcom Capital Markets Ltd.


Registrar to the Issue

Bigshare Services Pvt. Ltd.
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://ipo.bigshareonline.com/IPO_Status.html


Chanakya IPO Review (Initial View)

Phytochem Remedies operates in a steady, B2B-oriented packaging segment with diversified end-user industries. The company has demonstrated consistent improvement in revenues, EBITDA, and PAT, supported by healthy margins. However, debt levels remain elevated, which the IPO proceeds aim to partially reduce.

At an issue price of Rs. 98, investors should closely track subscription trends and GMP movement to gauge listing prospects.

Chanakya View: Suitable for informed SME investors with a medium-term perspective; listing gains will largely depend on subscription intensity and market sentiment.


Disclaimer:
This coverage is for informational and educational purposes only. Chanakya Ni Pothi does not recommend investments based on GMP or speculation. Please consult your SEBI-registered investment advisor before investing.


Quicklinks


Disclaimer

This coverage is for informational and educational purposes. Chanakya Ni Pothi does not deal in Grey Market Premiums or recommend investments based on GMP data. Please consult your SEBI-registered investment advisor.